Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Interest Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpense.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | $6,207 | $5,254 | $12,567 | $15,444 |
| Accretion of investment discount, net | 955 | 1,887 | 1,597 | 4,125 |
| Interest expense | (21,508) | (5,228) | (43,221) | (9,731) |
| (Loss) gain on strategic investments | (448) | 36,721 | (2,160) | (54,007) |
| Other, net | (246) | (573) | 918 | (902) |
| Total other (expense) income, net | $(15,040) | $38,061 | $(30,299) | $(45,071) |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — interest expense?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — interest expense of $21.51M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — interest expense changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — interest expense increased by 311.4% year-over-year, from $5.23M to $21.51M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — interest expense?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — interest expense has grown at a -10.5% compound annual growth rate (CAGR), from $53.25M to $38.14M.
- What does business segments — interest expense mean?
- The total cost of interest incurred on debt obligations specifically allocated to this business segment. It measures the financial burden of the segment's capital structure and leverage. High levels may indicate significant debt financing used to support segment operations or growth initiatives.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude